Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)

NCT: NCT07286201 · ENROLLING_BY_INVITATION

NCT IDNCT07286201
StatusENROLLING_BY_INVITATION
Start Date2026-03-19
Completion2027-08
SponsorPolyganics BV (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of the study is to evaluate the safety and effectiveness of OCEAN as an adjunct aid in wound healing after nasal/sinus surgery and to demonstrate that OCEAN is non-inferior compared to a steroid-eluting sinus stent.

Frequently Asked Questions

What is Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)?

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF) is a clinical trial registered under NCT07286201. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07286201?

The current status of NCT07286201 (Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)) is: ENROLLING_BY_INVITATION.

When did Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF) start?

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF) started on 2026-03-19.

Related Devices

K202623Novapak Nasal Sinus Packing and StentMedtronic Xomed

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑